GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EZZ Life Science Holdings Ltd (ASX:EZZ) » Definitions » PS Ratio

EZZ Life Science Holdings (ASX:EZZ) PS Ratio : 1.07 (As of Jun. 08, 2024)


View and export this data going back to 2021. Start your Free Trial

What is EZZ Life Science Holdings PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, EZZ Life Science Holdings's share price is A$1.095. EZZ Life Science Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$1.02. Hence, EZZ Life Science Holdings's PS Ratio for today is 1.07.

The historical rank and industry rank for EZZ Life Science Holdings's PS Ratio or its related term are showing as below:

ASX:EZZ' s PS Ratio Range Over the Past 10 Years
Min: 0.46   Med: 0.76   Max: 1.64
Current: 1.06

During the past 4 years, EZZ Life Science Holdings's highest PS Ratio was 1.64. The lowest was 0.46. And the median was 0.76.

ASX:EZZ's PS Ratio is ranked better than
91.42% of 1002 companies
in the Biotechnology industry
Industry Median: 9.53 vs ASX:EZZ: 1.06

EZZ Life Science Holdings's Revenue per Sharefor the six months ended in Dec. 2023 was A$0.51. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$1.02.

During the past 12 months, the average Revenue per Share Growth Rate of EZZ Life Science Holdings was 83.20% per year.

Back to Basics: PS Ratio


EZZ Life Science Holdings PS Ratio Historical Data

The historical data trend for EZZ Life Science Holdings's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EZZ Life Science Holdings PS Ratio Chart

EZZ Life Science Holdings Annual Data
Trend Jun20 Jun21 Jun22 Jun23
PS Ratio
- 0.68 0.88 0.57

EZZ Life Science Holdings Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PS Ratio Get a 7-Day Free Trial - 0.88 - 0.57 -

Competitive Comparison of EZZ Life Science Holdings's PS Ratio

For the Biotechnology subindustry, EZZ Life Science Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EZZ Life Science Holdings's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, EZZ Life Science Holdings's PS Ratio distribution charts can be found below:

* The bar in red indicates where EZZ Life Science Holdings's PS Ratio falls into.



EZZ Life Science Holdings PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

EZZ Life Science Holdings's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=1.095/1.024
=1.07

EZZ Life Science Holdings's Share Price of today is A$1.095.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. EZZ Life Science Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$1.02.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


EZZ Life Science Holdings  (ASX:EZZ) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


EZZ Life Science Holdings PS Ratio Related Terms

Thank you for viewing the detailed overview of EZZ Life Science Holdings's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


EZZ Life Science Holdings (ASX:EZZ) Business Description

Traded in Other Exchanges
N/A
Address
104 Derby Street, Silverwater, NSW, AUS, 2128
EZZ Life Science Holdings Ltd is a genomic life science company with a mission to improve quality of life and human health. EZZ has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. The company is engaged in formulation, production, marketing and sale of the EZZ branded health and wellbeing products to retailers and consumers domestically and internationally, and wholesale distribution of the EAORON branded skin care products to retailers in Australia and New Zealand.

EZZ Life Science Holdings (ASX:EZZ) Headlines

No Headlines